JPRN-UMIN000010163已完成未知
Effects of Aliskiren and Amlodipine Combination Therapy or High-dose Amlodipine Monotherapy on Ambulatory Blood Pressure in Hypertensive Patients - Aliskiren Combination with Amlodipine on Target Organ Damage: ACAT study
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine.0 个研究点目标入组 110 人开始时间: 2013年3月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Secondary hypertension 2) Moderate to severe symptom of heart failure (New York Heart Association >class III), fatal arrhythmia 3) A history of stroke, myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft within the past 6 months 4) Severe renal dysfunction (eGFR <30ml/min/1.73m2, or serum creatinine >2.0mg/dl) 5) Severe hepatic disease 6) Uncontrolled diabetes (HbA1c >12%) 7) Pregnant women 8) A history of allergy/hypersensitivity to dihydropyridine calcium channel blockers 9) Patients receiving other antihypertensive drugs than amlodipine 10) Patients receiving P-glycoprotein inhibitor 11) Severe dementia 12) Not eligible for this study based on the decision's of a physician
研究者
相似试验
Unknown
4 期
Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive PatientsHypertensionNCT01048047University of Pavia88
终止
2 期
Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With HypertensionAnkle EdemaHypertensionNCT01080768Novartis Pharmaceuticals31
已完成
3 期
Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine AloneHypertensionNCT00778921Novartis847
已完成
3 期
Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren AloneHypertensionNCT00777946Novartis818
已完成
4 期
Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II HypertensionStage II HypertensionNCT01070030Novartis230